<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-995</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕРОПРИЯТИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EVENTS</subject></subj-group></article-categories><title-group><article-title>Фишки OpenBio-2021: фудтех, Scopus и противодействие вирусам</article-title><trans-title-group xml:lang="en"><trans-title>OpenBio-2021 chips: foodtech, Scopus and countering viruses</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name><name name-style="western" xml:lang="en"><surname>Editorial</surname><given-names>Article</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>26</day><month>08</month><year>2021</year></pub-date><volume>10</volume><issue>3</issue><fpage>36</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Editorial a.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/995">https://www.pharmjournal.ru/jour/article/view/995</self-uri><abstract><p>С 5 по 8 октября в наукограде Кольцово Новосибирской области состоится международный научный конгресс в сфере биотехнологий, вирусологии и биофармацевтики OpenBio. Традиционно в его рамках пройдут научная конференция и бизнес-форум. Мероприятие организуют в гибридном формате: эксперты, спикеры и гости смогут участвовать онлайн.</p></abstract><trans-abstract xml:lang="en"><p>From October 5 to 8, the international scientific congress in the field of biotechnology, virology and biopharmaceuticals OpenBio will take place in the Koltsovo science city of the Novosibirsk region. Traditionally, a scientific conference and a business forum will be held within its framework. The event will be organized in a hybrid format: experts, speakers and guests can participate online.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
